Evidence map›Paper›PMID 38761187›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

[

Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, Elena Berg, Thilo Westhofen, Severin Rodler, Gerald B Schulz, Johannes Toms, Adrien Holzgreve, Franz J Gildehaus and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. [EJNMMI research · 2025
    Article
  3. Non-specific uptake ofBMC cancer · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lennert EismannDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Lennert.eismann@med.uni-muenchen.de.ORCID 0000-0002-9971-4411
Stephan T LedderoseInstitute of Pathology, LMU Munich, Munich, Germany Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Benazir EnzingerDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Elena BergDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Thilo WesthofenDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Severin RodlerDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Gerald B SchulzDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Johannes TomsDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Franz J GildehausDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Clemens C CyranDepartment of Radiology, University Hospital, LMU Munich, Munich, Germany.
Marcus UnterrainerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Christian G StiefDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Boris SchlenkerDepartment of Urology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Lena M UnterrainerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePenile cancer is a rare entity and has a good prognosis in localized stage. Delayed surgical treatment of lymphatic disease is associated with poor overall survival but conventional imaging cannot detect occult lymph node metastasis sufficiently. Imaging cancer related fibroblasts has shown promising results as non-invasive staging tool in various tumor entities but has not yet been evaluated in penile cancer.

methodsIn this single-center pilot study, patients planned for surgical treatment for penile cancer underwent preoperatively [

resultsFrom January 2022 to June 2022, a total number 11 patients with histopathologically proven penile cancer underwent surgery and received [

conclusionIn this first pilot cohort, there were no false-positive FAPI uptake which might allow the detection of occult lymph node metastasis by [

Indexed as

Feasibility StudiesPenile NeoplasmsPositron Emission Tomography Computed TomographyAgedGallium RadioisotopesHumansLymphatic MetastasisMaleMiddle AgedPilot ProjectsQuinolines68Ga-FAPIGallium RadioisotopesQuinolinesFAPIImagingLymph node stagingPenile cancerPET/scan

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.